Pacira BioSciences' Net Cash Flow fell 1396507.35% to -$153.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$98.7 million, marking a year-over-year decrease of 16722.21%. This contributed to the annual value of $123.5 million for FY2024, which is 15117.68% up from last year.
According to the latest figures from Q3 2025, Pacira BioSciences' Net Cash Flow is -$153.0 million, which was down 1396507.35% from $16.7 million recorded in Q2 2025.
Over the past 5 years, Pacira BioSciences' Net Cash Flow peaked at $451.5 million during Q4 2021, and registered a low of -$358.8 million during Q1 2022.
In the last 5 years, Pacira BioSciences' Net Cash Flow had a median value of $12.3 million in 2023 and averaged $2.5 million.
Per our database at Business Quant, Pacira BioSciences' Net Cash Flow skyrocketed by 188566.85% in 2021 and then crashed by 1396507.35% in 2025.
Quarter analysis of 5 years shows Pacira BioSciences' Net Cash Flow stood at $451.5 million in 2021, then tumbled by 101.17% to -$5.3 million in 2022, then skyrocketed by 1125.15% to $54.2 million in 2023, then tumbled by 43.13% to $30.8 million in 2024, then plummeted by 596.7% to -$153.0 million in 2025.
Its Net Cash Flow stands at -$153.0 million for Q3 2025, versus $16.7 million for Q2 2025 and $6.8 million for Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value